ArticleClinical pharmacokinetics2016

Population Pharmacokinetic Model of Cabozantinib in Patients with Medullary Thyroid Carcinoma and Its Application to an Exposure-Response Analysis.

Dale Miles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.